IL-17 and -23 Inhibitors for the Treatment of Psoriasis
Psoriasis is a chronic inflammatory skin condition with a significant global burden of disease and a wide array of potential treatment options, ranging from topical to systemic therapies. There are currently 11 biologic agents approved by the U.S. Food and Drug Administration (FDA) for the treatmen...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
European Medical Journal
2023-04-01
|
| Serie: | European Medical Journal Allergy & Immunology |
| Accesso online: | https://www.emjreviews.com/allergy-immunology/article/il-17-and-23-inhibitors-for-the-treatment-of-psoriasis/ |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|